Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trialChuanjie Wu, Lijun Wang, Yajun Lian et al.|Cephalalgia|2012Cited by 217
Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trialHaifeng Zhang, Chuanjie Wu, Yajun Lian et al.|The Journal of Headache and Pain|2014Cited by 170
LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cellsYuan Chen, Nanchang Xie, Yajun Lian et al.|NeuroToxicology|2017Cited by 103
Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous ThrombolysisChuanjie Wu, Xunming Ji, Chenghe Sun et al.|Stroke|2019Cited by 83
Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injuryChuanjie Wu, Xunming Ji, Qingfeng Ma et al.|Neurology|2020Cited by 79